Concord Biotech
Ahmedabad, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A leading Indian biopharmaceutical company specializing in fermentation-based APIs and formulations for infectious diseases and critical care, with global CDMO services.
Infectious DiseaseImmunologyNephrologyHematologyRheumatology
Technology Platform
Advanced microbial fermentation and semi-synthetic chemistry for the production of complex Active Pharmaceutical Ingredients (APIs).
Opportunities
Growth driven by global API/CDMO demand, expansion into injectable formulations, and leveraging new manufacturing capacity at its Limbasi facility to serve regulated markets.
Risk Factors
Regulatory compliance risks across multiple international agencies, intense competition in the API/CDMO sector, and potential pricing pressures in generic markets.
Competitive Landscape
Competes with other Indian fermentation and CDMO specialists like Biocon and Syngene. Differentiates through deep, niche fermentation expertise, vertical integration from API to formulation, and a strong track record with global regulators.